Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × Pharmaceutical Preparations × Clear all

NCT04238637 2025-12-05

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

Phase 2 Active not recruiting

Gastrointestinal

Cholangiocarcinoma